Company Overview and News

to your dashboard

Headline News

Cellmid to benefit from share consolidation as revenues grow

Cellmid Ltd (ASX:CDY) is proposing a consolidation of its securities at the ratio of 20 to 1 during the upcoming Annual General Meeting.

Cellmid's Maria Halasz discussed growing revenue streams at Proactive's CEO Sessions

Cellmid's (ASX:CDY) chief executive, Maria Halasz, joined Proactive's CEO Sessions in Sydney on Tuesday 3rd October and Melbourne on Tuesday 4th October.

Cellmid gets tax incentive for melanoma, hair growth research programs

Cellmid Limited (ASX:CDY) has received $947,000 from the Australian Taxation Office under the Research and Development Tax Incentive Scheme for the 2017 financial year.

Cellmid's Maria Halasz brings growing revenues to Proactive's CEO Sessions

Cellmid Ltd (ASX:CDY) continues to grow revenues from its consumer health division, through the wholly-owned subsidiary Advangen, which sells hair growth products. (1-0)

Gold Road to showcase Gruyere Joint Venture at the Proactive's CEO Sessions

Gold Road Resources Ltd (ASX:GOR) is pioneering development of Australia’s newest goldfield, the Yamarna Belt, 200 kilometres east of Laverton in Western Australia. (1-0)

Cobalt Blue's Joe Kaderavek to discuss next Thackaringa steps at Proactive's CEO Session in Sydney

Cobalt Blue Holdings (ASX:COB) is preparing for the next stage of field work, which is about to commence at its Thackaringa Cobalt Project near Broken Hill in New South Wales. (1-0)

Altech's Iggy Tan brings high purity alumina plans to Proactive's CEO Sessions

Altech Chemicals Ltd (ASX:ATC,FRA:A3Y) is aiming to become one of the world's leading suppliers of 99.99% (4N) high purity alumina (HPA). (1-0)

Silver City's Chris Torrey brings Copper Blow drilling program to Proactive's CEO Sessions

Silver City Minerals Ltd (ASX:SCI) is currently exploring in one of the best post codes in the world, being just 20 kilometres from Broken Hill in New South Wales. (1-0)

Mustang's Christiaan Jordaan to discuss ruby auction at Proactive's CEO Session in Melbourne

Mustang Resources Ltd's (ASX:MUS) managing director, Christiaan Jordaan, is preparing to showcase to investors details of the company's pending ruby auction at Proactive's CEO Session in Melbourne, (not available for Sydney). (1-0)

Cellmid secures new US partner for hair products

Cellmid (ASX:CDY) has secured a new partnership in the U.S. with premium retailer Neiman Marcus for its evolis® Professional products.

Cellmid receives China import permit for cosmetics

Cellmid Ltd (ASX:CDY) has had its import permits to China renewed for its for Jo-Ju® and Lexilis® cosmetic products.

Cellmid Limited gets a boost for its midkine assets

Cellmid Limited (ASX:CDY) has had results from a melanoma study related to midkine published by the prestigious and renowned journal, Nature.

Cellmid's Maria Halasz lifts stake on-market

Cellmid's (ASX:CDY) chief executive officer, Maria Halasz, has lifted her stake in the company through an on-market purchase.

Cellmid achieves record quarterly sales for hair loss products

Cellmid (ASX:CDY) has achieved record sales of $1.51 million for the March quarter, up 120% from the same period last year.

Cellmid's Maria Halasz buys shares on market

Cellmid (ASX:CDY) has had its managing director and CEO, Maria Halasz, purchase 400,000 shares on market recently.

Cellmid has hair loss technology published in journal

Cellmid (ASX:CDY) has had its FGF5 inhibitory hair loss technology published in a peer reviewed journal known as Clinical, Cosmetic, and Investigational Dermatology.

Cellmid bulks up research and development financing

Cellmid (ASX:CDY) has refinanced its $700,00 research and development loan agreement from February 2016 with a new larger $2 million facility.

Cellmid receives patent for midkine treatment in Europe

Cellmid's (ASX:CDY) patent for midkine (MK) treatment of alopecia has been allowed by the European Patent Office.

Cellmid gets green light for hair loss patent in U.S.

Cellmid (ASX:CDY) has been issued a notice of allowance for a patent entitled “Method of Treatment or Prevention of Hair Loss or for Enhancement of Hair Growth” by the U.S. Patent and Trademark Office.

Cellmid gets government backing for midkine research program

Cellmid (ASX:CDY) has received two Australian government grants totalling $100,000 to support research testing of its midkine (MK) antibodies for use in treatments.

Cellmid's Maria Halasz lifts stake with on-market purchase

Halasz purchased 350,000 for $9,124, increasing her direct position to 2.85 million shares (and 12 million loan shares), with her indirect position remaining at circa 12.5 million shares and 5 million unlisted options.

Cellmid expecting royalty payments from midkine license

Cellmid (ASX:CDY) to date has derived over $1.2 million from the midkine diagnostics license it issued to New Zealand based Pacific Edge in 2010.

Cellmid Ltd receives tax credit to bolster cash position

Cellmid Ltd (ASX:CDY) has received $831,000 from the Australian Taxation Office under the research and development tax incentive scheme for the 2016 financial year.

Cellmid Ltd launches hair loss products into US$3.5B market

Cellmid Ltd (ASX:CDY) has launched its lead revenue driving évolis® hair loss products into the U.S. market.

Cellmid Ltd secures funds to launch hair loss product in U.S.

Cellmid Ltd (ASX:CDY) has received commitments to raise $3 million through the placement of shares to sophisticated and institutional investors priced at $0.03.